Compared with normal tissues, SLC2A4 was significantly downregulated in patients with all subtypes and stages of BRCA, and high level of SCL2A4 in luminal A breast cancer and stage III breast cancer can significantly predict better prognosis. The gene discussed is SLC2A4; the disease is breast carcinoma.